SHetA2 treatment reduced cyclin D1 levels and induced G1 cell cycle arrest in both cancer and healthy cells, although the extents were greater in cancer over healthy cells (Liu et al., 2007; Liu et al., 2009; Masamha and Benbrook, 2009; Benbrook et al., 2017). This evidence concerns the gene CCND1 and cancer.